Chet Bohac

Chet Bohac

Company: Macrogenics

Job title: Senior Medical Director


Preliminary Dose Escalation Results from a Phase I/II, FIH Study of MGC018 in Patients with Advanced Solid Tumors 12:30 pm

• Examine B7H3 as a target for an ADC with a duocarmycin payload • Presenting a safety overview from Phase 1 Dose Escalation • Analyze efficacy from preliminary evidence of a Phase 1 enrollment with focus on prostate cancerRead more

day: day 1 track 3 am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.